Citadel Advisors - BIOCEPT INC ownership

BIOCEPT INC's ticker is BIOC and the CUSIP is 09072V501. A total of 32 filers reported holding BIOCEPT INC in Q1 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of BIOCEPT INC
ValueSharesWeighting
Q1 2023$4,457
-83.2%
13,109
-73.8%
0.00%
Q4 2022$26,498
-47.0%
49,996
-7.8%
0.00%
Q3 2022$50,000
-67.3%
54,200
-66.7%
0.00%
Q2 2022$153,000
-38.3%
162,664
+52.5%
0.00%
Q1 2022$248,000
-51.8%
106,631
-25.0%
0.00%
Q4 2021$515,000
+111.1%
142,151
+133.3%
0.00%
Q3 2021$244,000
-64.6%
60,924
-63.0%
0.00%
Q2 2021$690,000
-45.2%
164,813
-33.3%
0.00%
Q1 2021$1,258,000
+1723.2%
247,200
+1494.8%
0.00%
Q4 2020$69,00015,5000.00%
Other shareholders
BIOCEPT INC shareholders Q1 2022
NameSharesValueWeighting ↓
GLOBEFLEX CAPITAL L P 233,578$215,0000.04%
SABBY MANAGEMENT, LLC 30,502$28,0000.04%
Taylor & Morgan Wealth Management, LLC 26,000$24,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 109,436$101,0000.00%
CASTLE WEALTH MANAGEMENT LLC 1,350$1,0000.00%
VANGUARD GROUP INC 617,610$569,0000.00%
Focused Wealth Management, Inc 1$00.00%
UBS Group AG 12,356$11,0000.00%
OSAIC HOLDINGS, INC. 7,000$6,0000.00%
FMR LLC 1$00.00%
View complete list of BIOCEPT INC shareholders